Timetech Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.65 Cr
as on 12-12-2024
- Paid Up Capital ₹ 1.65 Cr
as on 12-12-2024
- Company Age 10 Year, 3 Months
- Last Filing with ROC 31 Mar 2022
About Timetech Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.65 Cr and a paid-up capital of Rs 1.65 Cr, as per Ministry of Corporate Affairs (MCA) records.
Nagaraju Gouth, Nagamani Gouth, Gouth Prabhanj, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24233TG2014PLC095659
- Company No.
095659
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
12 Sep 2014
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Timetech Lifesciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nagaraju Gouth  | Managing Director | 12-Sep-2014 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nagamani Gouth | Director | 12-Sep-2014 | Current |
| Gouth Prabhanj | Director | 12-Sep-2014 | Current |
| Yechuri Kishore | Director | 29-Aug-2016 | Current |
| Balaraju Edem | Director | 01-Feb-2023 | Current |
| Sajendra Linga | Director | 01-Feb-2023 | Current |
Financial Performance of Timetech Lifesciences.
Enhance accessibility to Timetech Lifesciences's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Timetech Lifesciences?
In 2016, Timetech Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Timetech Formulations LimitedActive 28 years 9 months
Nagaraju Gouth, Nagamani Gouth and 1 more are mutual person
- Edemera Global Private LimitedActive 4 years 4 months
Balaraju Edem and Sajendra Linga are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Timetech Lifesciences?
Unlock and access historical data on people associated with Timetech Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Timetech Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Timetech Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
